Idea principal
Pooling 20 trials with 1,289 adults with type 2 diabetes and overweight or obesity, combined aerobic and resistance training lowered body fat percentage (SMD -0.42), triglycerides (SMD -0.48) and LDL cholesterol (SMD -0.32) versus non-exercising controls, but did not change body mass. The authors rated the evidence quality as poor with uncertain risk of bias.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
People with type 2 diabetes and excess weight are often advised to exercise, and combining aerobic and resistance work (CART) may beat either alone. The authors pooled controlled trials to see how CART affects body composition, blood lipids and physical function in this group.
Población y método
Systematic review and meta-analysis. PubMed, Scopus, ScienceDirect, Cochrane Library and Google Scholar were searched from inception to August 7, 2024 for randomised and controlled clinical trials of CART. Risk of bias was assessed with the Cochrane tool and evidence reliability with GRADE. A random-effects model pooled results as standardised mean differences (SMD) with 95% confidence intervals (CI). The comparator was standard treatment, meaning non-exercising controls.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Of 22,878 studies retrieved, 20 were included, with data from 1,289 participants (57.0 ± 7.0 years; BMI 31.1 ± 4.6 kg/m2).
- 2CART reduced body fat percentage (SMD -0.42, 95% CI -0.70 to -0.15), triglycerides (SMD -0.48, 95% CI -0.71 to -0.24), total cholesterol (SMD -0.35, 95% CI -0.58 to -0.12) and LDL cholesterol (SMD -0.32, 95% CI -0.62 to -0.02). Fasting blood glucose was also significantly lower.
- 3CART raised HDL cholesterol (SMD 0.44, 95% CI 0.05 to 0.82), cardiorespiratory fitness (SMD 78.78, 95% CI 46.30 to 111.25) and muscular fitness (SMD 5.19, 95% CI 1.80 to 8.59).
- 4There were no significant differences in body mass, waist-to-hip ratio, fat mass or lean body mass.
Límites e incertidumbre
- 1The authors report uncertain risk of bias and poor quality of evidence in the included studies.
- 2The fitness SMDs of 78.78 and 5.19 are far larger than the other effects and look unusual for standardised differences, so they should be read with caution.
- 3The abstract does not give the number of studies per outcome, heterogeneity, or the training doses used.
- 4This reading is based on the abstract only.
Relevancia práctica
For adults with type 2 diabetes and excess weight, combining cardio and strength work is linked to better cholesterol, body fat percentage and fitness, though not to a lower scale weight. Because the evidence is rated poor, treat it as encouraging, and plan exercise with your diabetes care team.
Tus datos
Useful to track: strength sessions per week, weekly cardio minutes, VO2max estimate or resting heart rate trends, and waist or body fat percentage rather than weight alone. Lipids and glucose come from lab tests or a CGM; compare them under the same conditions over months.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
The potential advantages of concurrent aerobic and resistance training (CART) for enhancing cardiometabolic health-related outcomes appear to surpass the outcomes of engaging in aerobic or resistance training alone. The present study aimed to synthesize the available scientific evidence on the effects of CART on body composition, lipid metabolism, and physical function in patients with type 2 diabetes and overweight/obesity.
Methods
PubMed, Scopus, ScienceDirect, Cochrane Library, and Google Scholar were searched from inception to August 7, 2024. The review focused on randomized controlled trials and controlled clinical trials of CART. The Cochrane risk of bias tool was used to assess eligible studies, and the GRADE method to evaluate the reliability of evidence. A random-effects model was used and data were analyzed using standardized mean differences (SMD) and 95% confidence intervals (CI).
Results
A total of 22,878 studies were retrieved; only 20 studies were included, and data were extracted from 1,289 participants (57.0 ± 7.0 years; 31.1 ± 4.6 kg/m^(2)) who met the eligibility criteria. CART group significantly reduced body fat percentage (SMD -0.42, 95% CI [-0.70 to -0.15]), low-density lipoprotein-cholesterol (SMD -0.32, 95% CI [-0.62 to -0.02]), triglycerides (SMD -0.48, 95% CI [-0.71 to -0.24]), total cholesterol (SMD -0.35, 95% CI [-0.58 to -0.12]), and fasting blood glucose levels compared to standard treatment (non-exercising controls). CART significantly increased high-density lipoprotein-cholesterol (SMD 0.44, 95% CI [0.05-0.82]) and improved physical function (cardiorespiratory fitness: SMD 78.78, 95% CI [46.30-111.25]; muscular fitness: SMD 5.19, 95% CI [1.80-8.59]) compared to standard treatment. There were no significant differences in body mass, waist-to-hip ratio, fat mass, and lean body mass between CART and standard treatment. An uncertain risk of bias and poor quality of evidence were observed in the eligible studies.
Conclusions
The present results indicate clear evidence that CART has a beneficial role in the improvement of several cardiometabolic health-related parameters in patients with type 2 diabetes and concomitant overweight/obesity. More trials with robust methodological design are needed to investigate the dose-response effects, training parameters formation, and potential mechanisms.
Fuentes y atribución
Impact of concurrent aerobic and resistance training on body composition, lipid metabolism and physical function in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis.
Al-Mhanna SB, Alghannam AF, Alkhamees NH, Sheeha BB, Omar N, Albalawi H, Gülü M, Canli U, Afolabi HA, Abubakar BD, Badicu G, Ahmad R, Grivas GV, Batrakoulis A.
PeerJ · 2025-06-11
DOI: 10.7717/peerj.19537 ↗PubMed · 40520633 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

